These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics. Schaefer IM, Fletcher CD, Hornick JL. Mod Pathol; 2016 Jan; 29(1):4-13. PubMed ID: 26585554 [Abstract] [Full Text] [Related]
3. Immunohistochemical evaluation of H3K27 trimethylation in malignant peripheral nerve sheath tumors. Otsuka H, Kohashi K, Yoshimoto M, Ishihara S, Toda Y, Yamada Y, Yamamoto H, Nakashima Y, Oda Y. Pathol Res Pract; 2018 Mar; 214(3):417-425. PubMed ID: 29482987 [Abstract] [Full Text] [Related]
5. Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Cleven AH, Sannaa GA, Briaire-de Bruijn I, Ingram DR, van de Rijn M, Rubin BP, de Vries MW, Watson KL, Torres KE, Wang WL, van Duinen SG, Hogendoorn PC, Lazar AJ, Bovée JV. Mod Pathol; 2016 Jun; 29(6):582-90. PubMed ID: 26990975 [Abstract] [Full Text] [Related]
8. Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions. Le Guellec S, Macagno N, Velasco V, Lamant L, Lae M, Filleron T, Malissen N, Cassagnau E, Terrier P, Chevreau C, Ranchere-Vince D, Coindre JM. Mod Pathol; 2017 Dec; 30(12):1677-1687. PubMed ID: 28752843 [Abstract] [Full Text] [Related]
10. Immunohistochemistry for trimethylated H3K27 in the diagnosis of malignant peripheral nerve sheath tumours. Asano N, Yoshida A, Ichikawa H, Mori T, Nakamura M, Kawai A, Hiraoka N. Histopathology; 2017 Feb; 70(3):385-393. PubMed ID: 27580378 [Abstract] [Full Text] [Related]
11. Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss. Marchione DM, Lisby A, Viaene AN, Santi M, Nasrallah M, Wang LP, Williams EA, Larque AB, Chebib I, Garcia BA, Wojcik JB. Mod Pathol; 2019 Oct; 32(10):1434-1446. PubMed ID: 31175328 [Abstract] [Full Text] [Related]
13. Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status. Makise N, Sekimizu M, Kubo T, Wakai S, Hiraoka N, Komiyama M, Fukayama M, Kawai A, Ichikawa H, Yoshida A. Am J Surg Pathol; 2018 May; 42(5):656-664. PubMed ID: 29309298 [Abstract] [Full Text] [Related]
18. Malignant Peripheral Nerve Sheath Tumor of the Femur: A Rare Diagnosis Supported by Complete Immunohistochemical Loss of H3K27me3. Sugawara M, Kobayashi E, Asano N, Yoshida A, Kawai A. Int J Surg Pathol; 2017 Oct; 25(7):629-634. PubMed ID: 28508686 [Abstract] [Full Text] [Related]
19. Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile population. Patrizi S, Miele E, Falcone L, Vallese S, Rossi S, Barresi S, Giovannoni I, Pedace L, Nardini C, Masier I, Abballe L, Cacchione A, Russo I, Di Giannatale A, Di Ruscio V, Salgado CM, Mastronuzzi A, Ciolfi A, Tartaglia M, Milano GM, Locatelli F, Alaggio R. Clin Epigenetics; 2024 Jan 04; 16(1):9. PubMed ID: 38178234 [Abstract] [Full Text] [Related]
20. Loss of Histone H3K27 Trimethylation (H3K27me3) Expression as a Potential Diagnostic Pitfall in Sarcomatoid Carcinoma. Zilla ML, John I, Naous R. Int J Surg Pathol; 2024 Sep 04; 32(6):1089-1094. PubMed ID: 37997394 [Abstract] [Full Text] [Related] Page: [Next] [New Search]